rs28942109
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_016103.4(SAR1B):c.409G>A(p.Asp137Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,610,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016103.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAR1B | NM_016103.4 | c.409G>A | p.Asp137Asn | missense_variant | 6/7 | ENST00000402673.7 | NP_057187.1 | |
SAR1B | NM_001033503.3 | c.409G>A | p.Asp137Asn | missense_variant | 7/8 | NP_001028675.1 | ||
SAR1B | XM_047417257.1 | c.409G>A | p.Asp137Asn | missense_variant | 6/7 | XP_047273213.1 | ||
SAR1B | XM_047417258.1 | c.205G>A | p.Asp69Asn | missense_variant | 4/5 | XP_047273214.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAR1B | ENST00000402673.7 | c.409G>A | p.Asp137Asn | missense_variant | 6/7 | 1 | NM_016103.4 | ENSP00000385432.2 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151006Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 248362Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134238
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1459646Hom.: 0 Cov.: 34 AF XY: 0.0000427 AC XY: 31AN XY: 725948
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151006Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73606
ClinVar
Submissions by phenotype
Chylomicron retention disease Pathogenic:3Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 19, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2008 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 28, 2017 | The p.Asp137Asn (NM_001033503.2 c.409G>A) variant in SAR1B has been reported in at least 5 homozygous and 3 compound heterozygous individuals of French Canadian or White Canadian ancestry with Chylomicron retention disease and segregated in 5 family members (Charcosset 2008, Peretti 2009, and Jones 2003). This variant has also been reported in ClinVar (Variation ID#2923). This variant has been ide ntified in 0.004% (2/53,150) of European chromosomes by the Exome Aggregation Co nsortium (ExAC, http://exac.broadinstitute.org; dbSNP rs28942109). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tool s and conservation analysis suggest that the p.Asp137Asn variant may impact the protein, though this information is not predictive enough to determine pathogeni city. In summary, although additional studies are required to fully establish it s clinical significance, the p.Asp137Asn variant is likely pathogenic based upon biallelic case observations and segregation in affected individuals. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2023 | For these reasons, this variant has been classified as Pathogenic. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 2923). This missense change has been observed in individuals with Anderson's disease and/or chylomicron retention disease (PMID: 12692552, 17945526). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs28942109, gnomAD 0.005%). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 137 of the SAR1B protein (p.Asp137Asn). - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 22, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at